Oramed Pharmaceuticals Inc. (ORMP) Social Stream
ORAMED PHARMACEUTICALS INC (ORMP) Price Targets From Analysts
Use the tables below to see what analysts covering ORAMED PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-02 | 3 | $35 | $17 | $26.25 | $2.09 | 1155.98% |
| 2021-11-10 | 4 | $38 | $17 | $30 | $2.09 | 1335.41% |
| 2022-01-18 | 4 | $38 | $30 | $33.75 | $2.09 | 1514.83% |
| 2022-04-13 | 4 | $38 | $20 | $31 | $2.09 | 1383.25% |
| 2022-04-27 | 3 | $38 | $20 | $31 | $2.09 | 1383.25% |
| 2022-11-16 | 3 | $38 | $20 | $30 | $2.09 | 1335.41% |
| 2022-11-21 | 3 | $32 | $20 | $26.75 | $2.09 | 1179.9% |
| 2023-01-03 | 2 | $32 | $20 | $26.75 | $2.09 | 1179.9% |
| 2023-01-13 | 3 | $30 | $3 | $15.75 | $2.09 | 653.59% |
| 2023-01-25 | 3 | $30 | $2.8 | $10.2 | $2.09 | 388.04% |
The Trend in the Analyst Price Target
Over the past 19 months, ORMP's average price target has gone down $12.3.
Over the past 45 weeks, ORMP's average upside potential has been 310.82%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-15 | 3 | 38 | 20.0 | 30.00 | 9.91 | 202.72% |
| 2022-08-25 | 3 | 38 | 20.0 | 30.00 | 8.96 | 234.82% |
| 2022-11-21 | 2 | 32 | 20.0 | 26.75 | 7.81 | 242.51% |
| 2023-01-03 | 3 | 32 | 20.0 | 26.75 | 12.40 | 115.73% |
| 2023-01-25 | 3 | 30 | 2.8 | 10.20 | 2.06 | 395.15% |
ORMP Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 3 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 52 weeks, ORMP's average broker recommendation rating worsened by 1.33.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ORMP as an investment opportunity.
- ORMP has a greater upside potential (average analyst target price relative to current price) than 1159% of all US stocks.
- ORMP has a higher number of analysts covering the stock than 118.49% of all US stocks.
- In the context of stocks in the small market cap category, ORAMED PHARMACEUTICALS INC's average analyst price target is greater than 786.61% of them.
- In the context of stocks in the small market cap category, ORAMED PHARMACEUTICALS INC's variance in analysts' estimates is lower than -687.55% of them.
In the Pharmaceutical Products industry, OVID, FBRX, and OBSV are the three stocks most similar to ORAMED PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is ORMP a Buy, Hold or Sell? See the POWR Ratings now!